Skip to content

Neurogene Inc Sustainability Reports

Neurogene Inc. is a clinical-stage biotechnology company focused on developing genetic medicines for rare and devastating neurological diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900A7VIY892SZVW73

FIGI: BBG005Y0QF99

1 reports from 2023 to 2023